Actively Recruiting
AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
Led by Sohag University · Updated on 2026-05-13
200
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.
CONDITIONS
Official Title
AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3e= 18 years
- Both sexes
- Patients diagnosed with SLE who fulfill the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria
- Matched controls
You will not qualify if you...
- Co-existing chronic inflammatory or autoimmune diseases
- Age <18 years
- Malignancy
- Pregnancy or lactation
- Chronic liver or renal insufficiency
- Malignant hematologic diseases
- Active hepatitis
- Acute infection within the previous four weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag University hospitals
Sohag, Egypt
Actively Recruiting
Research Team
H
Hala A Hamid, Master
CONTACT
E
Esam M Abualfadl, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here